Literature DB >> 28839980

Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?

Martin W Dünser1, Jens Meier2.   

Abstract

Entities:  

Year:  2017        PMID： 28839980      PMCID： PMC5542935          DOI： 10.21037/jtd.2017.06.127

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

1.  Adjunctive use of a biologic pressor agent, angiotensin, in management of shock.

Authors:  J R DERRICK; J R ANDERSON; B J ROLAND
Journal:  Circulation       Date:  1962-01       Impact factor: 29.690

2.  Current approach to the haemodynamic management of septic shock patients in European intensive care units: a cross-sectional, self-reported questionnaire-based survey.

Authors:  Christian Torgersen; Martin W Dünser; Christian A Schmittinger; Ville Pettilä; Esko Ruokonen; Volker Wenzel; Stephan M Jakob; Jukka Takala
Journal:  Eur J Anaesthesiol       Date:  2011-04       Impact factor: 4.330

3.  Vasopressin pressor hypersensitivity in vasodilatory septic shock.

Authors:  D W Landry; H R Levin; E M Gallant; S Seo; D D'Alessandro; M C Oz; J A Oliver
Journal:  Crit Care Med       Date:  1997-08       Impact factor: 7.598

4.  Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis.

Authors:  Thiago D Corrêa; Victor Jeger; Adriano José Pereira; Jukka Takala; Siamak Djafarzadeh; Stephan M Jakob
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

Review 5.  Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure.

Authors:  A T Hirsch; Y M Pinto; H Schunkert; V J Dzau
Journal:  Am J Cardiol       Date:  1990-10-02       Impact factor: 2.778

6.  The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.

Authors:  M W Dünser; A J Mayr; H Ulmer; N Ritsch; H Knotzer; W Pajk; G Luckner; N J Mutz; W R Hasibeder
Journal:  Anesth Analg       Date:  2001-07       Impact factor: 5.108

Review 7.  Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress.

Authors:  Martin W Dünser; Walter R Hasibeder
Journal:  J Intensive Care Med       Date:  2009-08-23       Impact factor: 3.510

8.  Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock.

Authors:  Mary-Beth Malay; Jennifer L Ashton; Katherine Dahl; Edward B Savage; Sherryl A Burchell; Robert C Ashton; Robert R Sciacca; Juan A Oliver; Donald W Landry
Journal:  Crit Care Med       Date:  2004-06       Impact factor: 7.598

9.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

10.  Angiotensin II: a new approach for refractory shock management?

Authors:  Antoine Kimmoun; Bruno Levy
Journal:  Crit Care       Date:  2014-12-18       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.